PATENT CLAIM ANALYSIS

Application Number: 15946238
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-10
Patent Classification: ["514", "001100"]

Abstract:
The present invention provides a method of protecting the heart from damage, by administering to a patient at risk of such damage, a pharmaceutically effective amount of a composition which inhibits the interaction of RSK3 and mAKAPβ, or the expression or activity of one or both of those molecules. This composition may be in the form of a peptide that specifically inhibits mAKAPβ binding to RSK3 or in the form of an siRNA construct which inhibits the expression of RSK3.

Claim (Index 38):
The composition of  claim 33 , wherein the fragment is modified with a lipid-derived group.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 91.0
- Lexical Diversity: 1.7
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14821082', '14213583', '14800657', '10159971', '10801985']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.760831371834193
- 35 USC 102 Novelty (BERT): 0.6288848321288826
- Combined Prediction Score: 0.747636717863662
- Mean Citation Score: 433.209078
- Max Citation Score: 717.81464
- Similarity Product: 488.7396922262

Labels:
- Claim Label 101: 0
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test